Quest Diagnostics Reputation And At-Home Testing Efforts Catch Investor Attention

Quest Diagnostics Reputation And At-Home Testing Efforts Catch Investor Attention

Quest Diagnostics (NYSE:DGX) has been named to the Fortune 2026 World’s Most Admired Companies list, ranking…

Continue Reading
Quest Diagnostics Is Quietly Becoming Healthcare’s Operating System

Quest Diagnostics Is Quietly Becoming Healthcare’s Operating System

Quest Diagnostics is evolving from a lab test provider into a data-rich diagnostics platform that underpins…

Continue Reading
Guardant Health (NASDAQ:GH): Strongest Q3 Results from the Testing & Diagnostics Services Group

Guardant Health (NASDAQ:GH): Strongest Q3 Results from the Testing & Diagnostics Services Group

Earnings results often indicate what direction a company will take in the months ahead. With Q3…

Continue Reading
Guardant Health Announces Multi-Year Strategic Collaboration Agreement with Merck to Develop Companion Diagnostics and Commercialize New Cancer Therapies Using Guardant Infinity Smart Platform

Guardant Health Announces Multi-Year Strategic Collaboration Agreement with Merck to Develop Companion Diagnostics and Commercialize New Cancer Therapies Using Guardant Infinity Smart Platform

Multi-year global collaboration will utilize Guardant liquid biopsy portfolio for the development of companion diagnostics for…

Continue Reading
Quest Diagnostics Reputation And At-Home Testing Efforts Catch Investor Attention

Is Quest Diagnostics (DGX) Using At-Home STI Tests to Redefine Its Consumer Health Strategy?

In November 2025, Visby Medical announced that Quest Diagnostics’ consumer platform, questhealth.com, added the FDA-authorized at-home…

Continue Reading
Strongest Q3 Results from the Testing & Diagnostics Services Group

Strongest Q3 Results from the Testing & Diagnostics Services Group

Earnings results often indicate what direction a company will take in the months ahead. With Q3…

Continue Reading